HomeAPGE • NASDAQ
add
Apogee Therapeutics Inc
Previous close
$40.64
Day range
$40.17 - $42.21
Year range
$26.20 - $63.50
Market cap
2.42B USD
Avg Volume
693.88K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 63.10M | 65.25% |
Net income | -55.34M | -72.43% |
Net profit margin | — | — |
Earnings per share | -0.95 | -48.44% |
EBITDA | -62.89M | -64.84% |
Effective tax rate | -0.15% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 513.33M | -37.11% |
Total assets | 714.16M | -13.29% |
Total liabilities | 40.80M | 83.94% |
Total equity | 673.36M | — |
Shares outstanding | 58.31M | — |
Price to book | 3.52 | — |
Return on assets | -21.49% | — |
Return on capital | -22.31% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -55.34M | -72.43% |
Cash from operations | -48.48M | -53.23% |
Cash from investing | 12.98M | 125.09% |
Cash from financing | 622.00K | -99.86% |
Net change in cash | -34.87M | -109.50% |
Free cash flow | -27.90M | -36.06% |
About
Founded
2022
Headquarters
Website
Employees
196
